Angiosarcoma — Trials

Angiosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

53 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 10
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–13 of 13 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03331250	Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)	completed	Phase 2	13	Massachusetts General HospitalOTHER	1	Aug 28, 2026	clinicaltrials
NCT01303497	Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas(ANGIO-TAX+)	completed	Phase 2	70	Centre Oscar LambretOTHER	1	Mar 13, 2026	clinicaltrials